Hello and welcome to the details of UK health minister: Lilly weight-loss drug could help thousands and now with the details
Nevin Al Sukari - Sana'a - US and UK regulators today gave the thumbs up to Lilly’s weight-loss treatment Zepbound, also known as Mounjaro or tirzepatide, paving the way for a powerful new rival to Novo Nordisk’s Wegovy in addressing record obesity rates. — Reuters pic
LONDON, Nov 9 — Eli Lilly’s new weight-loss treatment, approved by the British health regulator today, has the potential to benefit thousands of obese Britons and could help the state-run National Health Service save billions of pounds, the health secretary said.
Advertisement
US and UK regulators today gave the thumbs up to Lilly’s weight-loss treatment Zepbound, also known as Mounjaro or tirzepatide, paving the way for a powerful new rival to Novo Nordisk’s Wegovy in addressing record obesity rates.
“Mounjaro has the potential to help thousands of people living with obesity and support those suffering from weight-related illnesses - if used alongside diet and physical activity,” Health Secretary Steve Barclay said in a statement.
“Tackling obesity could help cut waiting lists and save the NHS billions of pounds,” he said.
Advertisement
Barclay added that further approvals were needed before the drug can be covered by the NHS. — Reuters
Advertisement
These were the details of the news UK health minister: Lilly weight-loss drug could help thousands for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
